New black box warning for popular children’s asthma medication linked to reports of suicide

A new black box warning will be added to the asthma drug montelukast, marketed as Singulair, after reports of three suicides in Australia. Families have lobbied for over a decade due to side effects like nightmares and suicidal thoughts, with the TGA approving the warning to align with international regulators. Concerns over neuropsychiatric risks have led to further investigations and calls for cautionary advisory labels on the drug’s packaging.

Full Article